Cargando…
Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547613/ https://www.ncbi.nlm.nih.gov/pubmed/37561324 http://dx.doi.org/10.1007/s11095-023-03575-0 |
| _version_ | 1785115090491539456 |
|---|---|
| author | Yu, Yihua Bruce Briggs, Katharine T. Taraban, Marc B. |
| author_facet | Yu, Yihua Bruce Briggs, Katharine T. Taraban, Marc B. |
| author_sort | Yu, Yihua Bruce |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10547613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105476132023-10-05 Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance Yu, Yihua Bruce Briggs, Katharine T. Taraban, Marc B. Pharm Res Correction Springer US 2023-08-10 2023 /pmc/articles/PMC10547613/ /pubmed/37561324 http://dx.doi.org/10.1007/s11095-023-03575-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Yu, Yihua Bruce Briggs, Katharine T. Taraban, Marc B. Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title | Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title_full | Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title_fullStr | Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title_full_unstemmed | Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title_short | Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| title_sort | correction: preventive pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547613/ https://www.ncbi.nlm.nih.gov/pubmed/37561324 http://dx.doi.org/10.1007/s11095-023-03575-0 |
| work_keys_str_mv | AT yuyihuabruce correctionpreventivepharmacovigilancetimelyandprecisepreventionofadverseeventsthroughpersonlevelpatientscreeninganddoselevelproductsurveillance AT briggskatharinet correctionpreventivepharmacovigilancetimelyandprecisepreventionofadverseeventsthroughpersonlevelpatientscreeninganddoselevelproductsurveillance AT tarabanmarcb correctionpreventivepharmacovigilancetimelyandprecisepreventionofadverseeventsthroughpersonlevelpatientscreeninganddoselevelproductsurveillance |